Psychemedics Corporation Statistics
Share Statistics
Psychemedics Corporation has 5.89M shares outstanding. The number of shares has increased by 0.38% in one year.
| Shares Outstanding | 5.89M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.32% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 2.67M |
| Failed to Deliver (FTD) Shares | 109 |
| FTD / Avg. Volume | 0.33% |
Short Selling Information
The latest short interest is 13.85K, so 0.23% of the outstanding shares have been sold short.
| Short Interest | 13.85K |
| Short % of Shares Out | 0.23% |
| Short % of Float | 0.31% |
| Short Ratio (days to cover) | 0.79 |
Valuation Ratios
The PE ratio is -4.09 and the forward PE ratio is null.
| PE Ratio | -4.09 |
| Forward PE | null |
| PS Ratio | 0.77 |
| Forward PS | null |
| PB Ratio | 2.55 |
| P/FCF Ratio | -10.38 |
| PEG Ratio | n/a |
Enterprise Valuation
Psychemedics Corporation has an Enterprise Value (EV) of 17.32M.
| EV / Earnings | -4.17 |
| EV / Sales | 0.78 |
| EV / EBITDA | -69.02 |
| EV / EBIT | -5.93 |
| EV / FCF | -10.58 |
Financial Position
The company has a current ratio of 1.45, with a Debt / Equity ratio of 0.2.
| Current Ratio | 1.45 |
| Quick Ratio | 1.45 |
| Debt / Equity | 0.2 |
| Total Debt / Capitalization | 16.86 |
| Cash Flow / Debt | -1.09 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.62% and return on capital (ROIC) is -39.35%.
| Return on Equity (ROE) | -0.62% |
| Return on Assets (ROA) | -0.34% |
| Return on Capital (ROIC) | -39.35% |
| Revenue Per Employee | 190.50K |
| Profits Per Employee | -35.81K |
| Employee Count | 116 |
| Asset Turnover | 1.79 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 716.00K |
| Effective Tax Rate | -0.21 |
Stock Price Statistics
The stock price has increased by -10.4% in the last 52 weeks. The beta is 0.67, so Psychemedics Corporation's price volatility has been higher than the market average.
| Beta | 0.67 |
| 52-Week Price Change | -10.4% |
| 50-Day Moving Average | 2.37 |
| 200-Day Moving Average | 2.45 |
| Relative Strength Index (RSI) | 57.16 |
| Average Volume (20 Days) | 32.92K |
Income Statement
In the last 12 months, Psychemedics Corporation had revenue of $22.10M and earned -$4.15M in profits. Earnings per share was $-0.72.
| Revenue | 22.10M |
| Gross Profit | 8.41M |
| Operating Income | -2.92M |
| Net Income | -4.15M |
| EBITDA | -251.00K |
| EBIT | -2.92M |
| Earnings Per Share (EPS) | -0.72 |
Balance Sheet
The company has $1.96M in cash and $2.30M in debt, giving a net cash position of -$334.00K.
| Cash & Cash Equivalents | 1.96M |
| Total Debt | 2.30M |
| Net Cash | -334.00K |
| Retained Earnings | -16.77M |
| Total Assets | 9.84M |
| Working Capital | 2.25M |
Cash Flow
In the last 12 months, operating cash flow was -$1.48M and capital expenditures -$157.00K, giving a free cash flow of -$1.64M.
| Operating Cash Flow | -1.48M |
| Capital Expenditures | -157.00K |
| Free Cash Flow | -1.64M |
| FCF Per Share | -0.29 |
Margins
Gross margin is 38.07%, with operating and profit margins of -13.22% and -18.8%.
| Gross Margin | 38.07% |
| Operating Margin | -13.22% |
| Pretax Margin | -15.56% |
| Profit Margin | -18.8% |
| EBITDA Margin | -1.14% |
| EBIT Margin | -13.22% |
| FCF Margin | -7.41% |
Dividends & Yields
PMD pays an annual dividend of $0.14, which amounts to a dividend yield of 5.24%.
| Dividend Per Share | $0.14 |
| Dividend Yield | 5.24% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | -27.45% |
| Earnings Yield | -26.97% |
| FCF Yield | -10.4% |
Analyst Forecast
Currently there are no analyst rating for PMD.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Aug 1, 2002. It was a backward split with a ratio of 1:4.
| Last Split Date | Aug 1, 2002 |
| Split Type | backward |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | 0.83 |
| Piotroski F-Score | 6 |